Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 6/11/14  and contains information from public web pages and contributions from the ZoomInfo community.

Ms. Pamela A. Hay

Wrong Pamela A. Hay?

Partner

Red Sky Partners, LLC.
P.O. Box 920327
Needham, Massachusetts 02492
United States

 
Background

Employment History

Board Memberships and Affiliations

Education

  • J.D.
  • BA , Biology
    Cornell University
  • JD
    University of Wisconsin
22 Total References
Web References
Team - Red Sky Partners
www.redskyco.com, 7 Nov 2013 [cached]
Pamela Hay
Lead negotiator on more than 100 licensing, partnering and M&A life sciences deals, including managing the selling, buying and diligence processes.
...
Pamela has more than 20 years of business development and legal experience working in private and public biotechnology companies. Prior to founding Red Sky Partners in early 2009, she had her own business strategy and operations consulting practice focusin on early stage biotechnology companies. Pamela was Chief Commercial Officer at Domantis Ltd from October 2001 until its acquisition by GSK for $450M in Jan 2007. At Domantis, she was responsible for business development, IP licensing, and diligence and legal activities, including the establishment of partnerships with Abbott and Bristol-Myers Squibb and multi-party negotiations that led to the company's sale to GSK.
Before joining Domantis, Pamela was SVP, Corporate Development at Dyax Corp, where she designed and implemented the company's broad-based licensing program for phage display IP and technology, in addition to the negotiation and execution of multiple corporate and academic partnerships and management of IP and legal matters (including for the company's 2000 IPO). Her prior positions include General Counsel of T Cell Sciences and Corporate Attorney for Biogen. Pamela has a BA in Biology from Cornell University and a JD from the University of Wisconsin.
photo: Pamela Hay
NeuroHealing Pharmaceuticals Inc.
www.neurohealing.com, 19 April 2014 [cached]
Pamela Hay, J.D.
...
Pamela Hay, J.D. Pamela Hay is a business development and operations consultant for early stage biotechnology companies. She was Chief Commercial Officer at Domantis Ltd from 2001 until its acquisition by GSK in 2007, where she oversaw commercial development, including completion of major alliances with Abbott and BMS and additional deal negotiations that concluded the companys purchase. Previously, she was SVP, Corporate Development at Dyax Corp where she was responsible for the negotiation of more than 60 licenses and collaborations as well as the legal and IP functions. She has also held senior legal positions at T Cell Sciences and Biogen. Pamela has a JD from the University of Wisconsin and a BA in Biology from Cornell University.
PharmaLive
www.medadnews.com, 21 July 2001 [cached]
In the area of Corporate Development , Jack Morgan has joined the company as Senior Vice President , Corporate Development & Business Operations , and Pamela Hay , JD , has been appointed Senior Vice President , Corporate Development & Strategic Opportunities.
...
Ms. Hay joined Dyax in 1995 as Director of Licensing and Legal Affairs.Since that time , she conceived of and developed Dyax's very successful licensing programs.
News & Headlines: Diversys Names Pamela Hay Chief Commercial Officer
www.otohns.net, 14 Mar 2014 [cached]
2001 NOV 12 - (NewsRx.com & NewsRx.net) -- Diversys Ltd., a protein engineering company, has hired business development executive Pamela Hay as chief commercial officer. Ms. Hay is considered an expert in the developing business opportunities in the fields of protein repertoires and protein engineering, and is a prolific negotiator of deals in this sector, according to the company.
...
Ms. Hay has more than 15 years of legal and business development experience with major biotechnology and pharmaceutical companies. With a degree in biology from Cornell and a law degree from the University of Wisconsin. She joined Dyax Corp. in 1996, where she rose to become senior vice president of corporate development and strategic opportunities. Within Dyax, Ms. Hay and her team negotiated over 75 collaboration, technology transfer and license agreements involving the company's phage display technology and product leads, managed the company's growing patent portfolio and legal needs, and helped lead the acquisition of new technologies. Ms. Hay will assume responsibility for the commercialization of Diversys' protein repertoire and engineering technologies for therapeutic, diagnostic and research use. In addition, she will be in charge of business development activities and management of Diversys intellectual property portfolio. Ms. Hay will be based in Diversys' new commercial office in Cambridge, Massachusetts. This article was prepared by Health & Medicine Week editors from staff and other reports.
Domantis
www.domantis.com, 11 Oct 2001 [cached]
DIVERSYS APPOINTS PAMELA HAY AS CHIEF COMMERCIAL OFFICER Former Senior Vice President of Dyax Joins Diversys
Cambridge, UK and Cambridge, USA, October 11, 2001 ... Diversys Limited, the protein engineering company, today announced that the prominent business development executive Pamela Hay has joined the company as Chief Commercial Officer.Ms Hay is considered an expert in the developing business opportunities in the fields of protein repertoires and protein engineering.She is also one of the more prolific negotiators of deals in this sector.
...
Pamela Hay has over 15 years of legal and business development experience with major biotechnology and pharmaceutical companies.With a degree in biology from Cornell and a law degree from the University of Wisconsin, Ms Hay worked for 5 years with Biogen as Corporate Counsel, where her responsibilities included managing the Company's patent estate and negotiation of business transactions.Ms Hay negotiated deals with SmithKline Beecham, Abbott Laboratories and with Merck for Biogen's hepatitis B patent estate.Ms Hay moved on to become General Counsel for T Cell Sciences, now Avant Immunotherapeutics, where she led the Company's legal and intellectual property activities.
Ms Hay joined Dyax Corp. in 1996, where she rose to become Senior Vice President of Corporate Development and Strategic Opportunities.Within Dyax, Ms Hay and her team negotiated over 75 collaboration, technology transfer and license agreements involving the Company's phage display technology and product leads, managed the Company's growing patent portfolio and legal needs, and helped lead the acquisition of new technologies.
Ms Hay will assume responsibility for the commercialisation of Diversys' protein repertoire and engineering technologies for therapeutic, diagnostic and research use.In addition, she will be in charge of business development activities and management of Diversys intellectual property portfolio.Ms Hay will be based in Diversys' new commercial office in Cambridge, Massachusetts in the USA.
Other People with the name "Hay":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304